TRADING QUOTES 3:20 AM March 24, 2023
IPO Terms Details
Business Combination
Related Articles
SEC Filings
SPAC Name : Aesther Healthcare Acquisition Corp.
| Total Public Proceeds at IPO($mm): | 105.0 |
| %Held in Trust: | 102.0 |
| $Held in Trust per Unit: | $ 10.20 |
| Mgmt's Sector Expertise/Focus: | BioTech |
| IPO Date: | 2021-09-15 |
| Months to Complete: | 12 |
| Deadline Date: | 2023-03-16 |
| Unit Structure (AEHAU) | |
| Share (AEHA): | 1 Share Class A Common Stock |
| Warrant (AEHAW) | 1/2 Warrant |
| Right() | |
| Public Warrant Terms: | |
| Exercise Price: | 11.500000000 |
| Redemption Price: | Cash/Cashless: $18.00 |
| Redemption: Cash, Cashless or for Shares | Mgmt's Discretion |
| Underwriters: | |
| Book-runner(s): | EF Hutton |
| Co-Manager(s): | |
| Fees (Upfront/Deferred): | 1.0%/3.0% |
| Lawyers: | |
| Issuer's Counsel: | The Loev Law Firm, PC |
| Underwriter's Counsel: | Schiff Hardin LLP |
| Additional Terms: | Crescent term: $9.20, Limitation on redemption rights: 15% |
SPAC Name: Aesther Healthcare Acquisition Corp.
| CURRENT FUNDS in TRUST: | $110,667,764* |
| EST. PRO RATA AMOUNT IN TRUST: | $10.54* |
| IMPLIED ENTERPRISE VALUE: | $274.875 million |
| RECORD DATE: | 2023-01-11 |
| SHAREHOLDER VOTE DATE: | 2023-02-14 |
| SPAC NameSource: SEC.gov filings and SPAC Insider estimates | |
|---|---|